KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Net Cash Flow (2016 - 2025)

Cvs Health (CVS) has disclosed Net Cash Flow for 17 consecutive years, with -$640.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 136.7% year-over-year to -$640.0 million, compared with a TTM value of -$6.6 billion through Dec 2025, down 1945.4%, and an annual FY2025 reading of -$172.0 million, down 147.91% over the prior year.
  • Net Cash Flow was -$640.0 million for Q4 2025 at Cvs Health, up from -$2.7 billion in the prior quarter.
  • Across five years, Net Cash Flow topped out at $2.7 billion in Q2 2024 and bottomed at -$6.7 billion in Q2 2023.
  • Average Net Cash Flow over 5 years is -$1.9 billion, with a median of -$2.4 billion recorded in 2023.
  • The sharpest move saw Net Cash Flow crashed 424.91% in 2022, then soared 252.78% in 2023.
  • Year by year, Net Cash Flow stood at -$4.4 billion in 2021, then grew by 2.2% to -$4.3 billion in 2022, then skyrocketed by 48.0% to -$2.2 billion in 2023, then surged by 178.77% to $1.7 billion in 2024, then plummeted by 136.7% to -$640.0 million in 2025.
  • Business Quant data shows Net Cash Flow for CVS at -$640.0 million in Q4 2025, -$2.7 billion in Q3 2025, and -$218.0 million in Q2 2025.